Skip to main content
logo
Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
13.62
+0.02 (0.15%)
Apr 13, 2026, 9:40 AM EDT - Market open

Apollomics Revenue

Apollomics had revenue of $8.50M in the half year ending June 30, 2025, with 1,641.80% growth. This brings the company's revenue in the last twelve months to $6.93M, up 229.84% year-over-year. In the year 2024, Apollomics had annual revenue of $198.00K, down -75.88%.

Revenue (ttm)
$6.93M
Revenue Growth
+229.84%
P/S Ratio
4.21
Revenue / Employee
$533,077
Employees
13
Market Cap
29.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024198.00K-623.00K-75.88%
Dec 31, 2023821.00K498.00K154.18%
Dec 31, 2022323.00K321.00K16,050.00%
Dec 31, 20212.00K-1.84M-99.89%
Dec 31, 20201.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Kyntra Bio6.44M
Marker Therapeutics3.55M
Dyadic International3.09M
IGC Pharma1.11M
Daré Bioscience1.03M
INmune Bio50.00K
Senti Biosciences22.00K
Revenue Rankings

APLM News

More News